AI-generated summary
The authors ran a randomized, placebo-controlled, double-blind crossover study of 48 patients with primary Raynaud's phenomenon, comparing low level laser therapy with sham treatment over 3 weeks each. They report that attack number and intensity were significantly reduced during laser therapy, while thermographic measures did not reach statistical significance.
- Participants
- 48
- Who or what was studied
- Patients with primary Raynaud's phenomenon
- Limits stated in the abstract
- The abstract does not state the laser wavelength and reports that thermographic parameters did not reach statistical significance.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Sham, Statistical significance, Crossover study. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.